LSX Investival Showcase London 2026
Panel Headliner Stage track
Investing Across MedTech & Biotech: Decoding Investor Appetite and Risk Perception
Mon, Nov 16, 2026 · 2:45–3:30 PM GMT Old Billingsgate
About this session
The investment landscape for medtech and biotech presents distinct opportunities and challenges that shape how venture capitalists deploy capital across these sectors. While biotech companies routinely secure substantial Series A rounds, medtech ventures face a markedly different funding reality—characterized by smaller exits, fewer strategic buyers, and a paradoxical risk perception that often positions medtech as the "riskier" bet.
